Walleye Capital’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Walleye Capital’s Portfolio SXTPW Stock Details SXTPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.05K	Hold	200,481	–	–	﹤0.01%	4531
2026 Q1	$10K	Sell	200,481 -799	-0.4%	-$51	﹤0.01%	4161
2025 Q4	$12.6K	Sell	201,280 -21,626	-10%	-$1.06K	﹤0.01%	4286
2025 Q3	$8.25K	Hold	222,906	–	–	﹤0.01%	4289
2025 Q2	$12.6K	Hold	222,906	–	–	﹤0.01%	4285
2025 Q1	$5.13K	Hold	222,906	–	–	﹤0.01%	4102
2024 Q4	$6.62K	Hold	222,906	–	–	﹤0.01%	4607
2024 Q3	$12.8K	Hold	222,906	–	–	﹤0.01%	4884
2024 Q2	$15.6K	Hold	222,906	–	–	﹤0.01%	5160
2024 Q1	$16.9K	Hold	222,906	–	–	﹤0.01%	4969
2023 Q4	$11.1K	Hold	222,906	–	–	﹤0.01%	4550
2023 Q3	$78K	Buy	+222,906	New	+$95.7K	﹤0.01%	4041

Other funds holding SXTPW

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Torno Capital Cohasset, Massachusetts $3.47B AUM 37.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Walleye Capital's SXTPW Position: Q2 2026 in Review

Walleye Capital held its 60 Degrees Pharmaceuticals Warrant (SXTPW) position steady in Q2 2026 at 200,481 shares worth $6.05K. The position accounts for ﹤0.01% of the portfolio, ranked #4531.

Walleye Capital first reported a position in SXTPW in Q3 2023 and has held it in 12 quarters since. The position peaked at $78K in Q3 2023. 5 funds tracked by Wall St. Rank hold SXTPW as of Q2 2026.

Walleye Capital held 200,481 shares of 60 Degrees Pharmaceuticals Warrant worth $6.05K as of Q2 2026.
Walleye Capital left its 60 Degrees Pharmaceuticals Warrant share count unchanged in Q2 2026.
60 Degrees Pharmaceuticals Warrant made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4531 holding.
Walleye Capital first reported a position in 60 Degrees Pharmaceuticals Warrant in Q3 2023 and has held it in 12 quarters since.
Walleye Capital's 60 Degrees Pharmaceuticals Warrant position peaked at $78K in Q3 2023.
5 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.